A Pilot Study on Exercise After Achilles Tendon Rupture (NEMEX-ATR)

December 22, 2022 updated by: Region Skane

NEMEX-ATR: A Randomized Pilot Study on Early Neuromuscular Exercise in Non-surgically Treated Achilles Tendon Rupture

The purpose is to study the effect of early NEuroMuscular EXercise (NEMEX) versus conventional treatment (late exercise) in patients with acute non-operative achilles tendon rupture (ATR).

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

There is currently no consensus on treatment for achilles tendon rupture with regard to surgical or non-surgical treatment. In addition, the optimal time to start exercise treatment after the injury, with or without surgery, is not well understood. Animal studies show positive effects of early mobilization in tendon healing. Neuromuscular exercise has shown better effects than strength exercise in people with knee injury or knee disease. There are few studies in humans focusing on exercise as treatment, without surgical intervention, after ATR.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Skåne
      • Lund, Skåne, Sweden, 222 37
        • Skåne University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 58 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Men and women 18 - 60 years.
  2. The patient should before the achilles tendon rupture have been able to walk independently without aid, walk without limping, run/jog and be able to jump on one leg
  3. The patient shall be able to read, understand and to assimilate the written information about the study.

Exclusion Criteria:

  1. Previous achilles tendon rupture
  2. Acute achilles tendon rupture, more than 5 days.
  3. Medical restrictions regarding physical exercise, not related to the achilles tendon rupture

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Early neuromusclar exercise
30 patients are randomized to early neuromuscular exercise (n=15) or treatment as usual, i.e., late exercise (n=15). Both groups are given an orthosis and are instructed to wear this for eight weeks. The experimental group starts with a structured exercise program one week after the diagnosis. The patients attend one training session/week during eight weeks, guided by a physical therapist. The level of training is progressed during this time. The patients in the control group (treatment as usual) are given exercise instructions and information at one occasion; 2 weeks after diagnosis. Both groups are followed up, by a blinded assessor, with valid and reliable self-reported and physical function outcomes at 1, 4, 8 and 16 weeks after injury.
Other Names:
  • Treatment as usual (late exercise)
Active Comparator: Treatment as usual (late training)
30 patients are randomized to early neuromuscular exercise (n=15) or treatment as usual, i.e., late exercise (n=15). Both groups are given an orthosis and are instructed to wear this for eight weeks. The experimental group starts with a structured exercise program one week after the diagnosis. The patients attend one training session/week during eight weeks, guided by a physical therapist. The level of training is progressed during this time. The patients in the control group (treatment as usual) are given exercise instructions and information at one occasion; 2 weeks after diagnosis. Both groups are followed up, by a blinded assessor, with valid and reliable self-reported and physical function outcomes at 1, 4, 8 and 16 weeks after injury.
Other Names:
  • Treatment as usual (late exercise)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heel-raise
Time Frame: Week 16
Functional performance of calf muscles. The ability to perform a plantar flexion is assessed in a prone position at 1 and 4 weeks after the injury. At 8 and 16 weeks after the injury, the ability to perform a heel-raise standing on one leg is assessed.
Week 16

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Single limb standing balance
Time Frame: At weeks 4, 8 and 16
The patients stands on one leg with eyes open as long as possible, maximum time 60 seconds. Both legs are tested.
At weeks 4, 8 and 16
30-meters walk test
Time Frame: At weeks 8 and 16
The patients walks a distance of 30 m at self-selected speed. Time and any limbing is recorded.
At weeks 8 and 16
Single-limb mini squat
Time Frame: At week 16
The patients performs single-limb mini squats. The position of the knee in relation to the foot is assessed. The test is performed on both legs.
At week 16
VAS Pain
Time Frame: At weeks 1, 4, 8 and 16
The patients reports pain on a 0-10 visual analog scale.
At weeks 1, 4, 8 and 16
Range of Motion
Time Frame: At weeks 1, 4, 8 and 16
The range of plantar and dorsal flexion motions in the talocrural joint are measured with a handheld goniometer.
At weeks 1, 4, 8 and 16
The calf muscle circumference
Time Frame: At weeks 1, 4, 8 and 16
Calf muscle circumference is recording using a measuring-tape.
At weeks 1, 4, 8 and 16
Foot and Ankle Outcome Score (FAOS)
Time Frame: At weeks 1, 4, 8 and 16
A disease specific questionnaire for patients with foot and ankle injury.
At weeks 1, 4, 8 and 16
Short-Form 36 (SF-36)
Time Frame: At weeks 1, 4, 8 and 16
A generic measure of health status.
At weeks 1, 4, 8 and 16
Physical Activity Level Scale
Time Frame: At weeks 1, 4, 8 and 16
A scale that measures the patient's level of daily physical activity.
At weeks 1, 4, 8 and 16
Re-rupture
Time Frame: Weeks 1-16
Joint specific adverse event; recorded by any patient seeking medical care related to the achilles tendon rupture during the study period.
Weeks 1-16
Deep Venous thromboembolism
Time Frame: Weeks 1-16
Joint specific adverse event; recorded by any patient seeking medical care related to the achilles tendon rupture during the study period.
Weeks 1-16
Sick leave
Time Frame: Measured regularly from baseline until week 16
The number of weeks the patient are not at work caused of the achilles tendon rupture is registered.
Measured regularly from baseline until week 16
Modified Forward lunge from stairs
Time Frame: week 16
The patient stands on the first step of a staircase and is encouraged to take step down with one leg, the other leg kept on the step. The examiner stands in front of the patient and observes position of joints in relation to each other.
week 16

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Study Director: Eva Ageberg, PT, PhD, Lund University
  • Study Director: Sylvia Resch, MD, PhD, Skåne University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2011

Primary Completion (Actual)

April 1, 2013

Study Completion (Actual)

April 1, 2013

Study Registration Dates

First Submitted

February 9, 2011

First Submitted That Met QC Criteria

February 16, 2011

First Posted (Estimate)

February 17, 2011

Study Record Updates

Last Update Posted (Estimate)

December 23, 2022

Last Update Submitted That Met QC Criteria

December 22, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2010/173

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Achilles Tendon Rupture

Clinical Trials on Early Neuromuscular Exercise

3
Subscribe